Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/42/4d/8b/424d8bd5-9fbd-b1e4-5461-106fbdb9f385/mza_6610988476650408252.jpg/600x600bb.jpg
Molecular Modelling and Drug Discovery
Valence Discovery
60 episodes
6 days ago
Welcome to this space dedicated to the M2D2 Talks co-organized by Valence Discovery and Mila - Quebec AI Institute. From applied research papers to open source projects, we're hoping to use these talks to help demystify AI for drug discovery and make the field more accessible for newcomers. M2D2 will bring our vibrant AI & drug discovery communities together and spark new perspectives, provoke discussions, and offer a safe space to share new ideas. For the best experience, please visit our YouTube channel where slides and video presentations can be referenced.
Show more...
Science
RSS
All content for Molecular Modelling and Drug Discovery is the property of Valence Discovery and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to this space dedicated to the M2D2 Talks co-organized by Valence Discovery and Mila - Quebec AI Institute. From applied research papers to open source projects, we're hoping to use these talks to help demystify AI for drug discovery and make the field more accessible for newcomers. M2D2 will bring our vibrant AI & drug discovery communities together and spark new perspectives, provoke discussions, and offer a safe space to share new ideas. For the best experience, please visit our YouTube channel where slides and video presentations can be referenced.
Show more...
Science
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/27286797/27286797-1656636766469-f7c96f4311f76.jpg
Structure-Independent Peptide Binder Design via Generative Language Models | Pranam Chatterjee
Molecular Modelling and Drug Discovery
1 hour 54 seconds
2 years ago
Structure-Independent Peptide Binder Design via Generative Language Models | Pranam Chatterjee

[DISCLAIMER] - For the full visual experience, we recommend you tune in through our ⁠⁠⁠⁠⁠⁠⁠⁠YouTube channel ⁠⁠⁠⁠⁠⁠⁠⁠to see the presented slides.

Try datamol.io - the open source toolkit that simplifies molecular processing and featurization workflows for machine learning scientists working in drug discovery: ⁠⁠⁠⁠⁠https://datamol.io/⁠⁠⁠⁠⁠

If you enjoyed this talk, consider joining the ⁠⁠⁠⁠⁠⁠⁠⁠Molecular Modeling and Drug Discovery (M2D2) talks⁠⁠⁠⁠⁠⁠⁠⁠ live.

Also, consider joining the ⁠⁠⁠⁠⁠⁠⁠⁠M2D2 Slack⁠⁠⁠⁠⁠⁠⁠⁠.

Abstract: The ability to modulate pathogenic proteins represents a powerful treatment strategy for diseases. Unfortunately, many proteins are considered “undruggable” by small molecules, and are often intrinsically disordered, precluding the usage of structure-based tools for binder design. To address these challenges, we have developed a suite of algorithms that enable the design of target-specific peptides via protein language model embeddings, without the requirement of 3D structures. First, we train a model that leverages ESM-2 embeddings to efficiently select high-affinity peptides from natural protein interaction interfaces. We experimentally fuse model-derived peptides to E3 ubiquitin ligases and identify candidates exhibiting robust degradation of undruggable targets in human cells. Next, we develop a high-accuracy discriminator, based on the CLIP architecture, to prioritize and screen peptides with selectivity to a specified target protein. As input to the discriminator, we create a Gaussian diffusion generator to sample an ESM-2-based latent space, fine-tuned on experimentally-valid peptide sequences. Finally, to enable de novo generation of binding peptides, we train an instance of GPT-2 with protein interacting sequences to enable peptide generation conditioned on target sequence. Our model demonstrates low perplexities across both existing and generated peptide sequences. Together, our work lays the foundation for programmable protein targeting and editing applications.


Speaker: Pranam Chatterjee

Twitter -  ⁠⁠⁠⁠⁠⁠⁠⁠Prudencio⁠⁠⁠⁠⁠⁠⁠⁠

Twitter - ⁠⁠⁠⁠⁠⁠⁠⁠Jonny⁠⁠⁠⁠⁠⁠⁠⁠

Twitter - ⁠⁠⁠⁠⁠⁠⁠⁠datamol.io

Molecular Modelling and Drug Discovery
Welcome to this space dedicated to the M2D2 Talks co-organized by Valence Discovery and Mila - Quebec AI Institute. From applied research papers to open source projects, we're hoping to use these talks to help demystify AI for drug discovery and make the field more accessible for newcomers. M2D2 will bring our vibrant AI & drug discovery communities together and spark new perspectives, provoke discussions, and offer a safe space to share new ideas. For the best experience, please visit our YouTube channel where slides and video presentations can be referenced.